ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 30915 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 30915; 2) Community: the network communities that were significantly associated with the response to NSC 30915; 3) Molecule: the relationships between components within communities and NSC 30915; 4) MDR: the compounds that were significantly associated with the NSC 30915.

NSC Compound Enrichment Correlation
NSC 750762 2-methoxy-7-benzyl-3-(phenylsulfonyl)-6,7-dihydro-5H-pyrazolo[3,4-h]quinoline 0.0164116791870034 0.1589147
NSC 756173 GSK326090A 0.0164116791870034 0.07970642
NSC 762009 Copper(II) complex with quin as a ligand 0.0164116791870034 0.52233291
NSC 87500 Solacongestidine 0.0164116791870034 0.23472938
NSC 123814 Null 0.0164116791870036 0.23653278
NSC 157995 Benzo[c]phenanthridinium, 2-hydroxy-3,8,9-trimethoxy-5-methyl-, chloride (9CI) (MF1) 0.0164116791870036 -0.12331481
NSC 319730 ORIDONIN (THIOL ADDUCT OF) 0.0193573267900279 0.42111621
NSC 338304 Iron, dichloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydraziato] 0.0193573267900279 0.48041379
NSC 618857 4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride 0.0193573267900279 -0.12857551
NSC 620517 Naphtho[2,1-b]furan-6,9-dione, 7-chloro-1,2-dihydro- 5-hydroxy-2-methoxy-2,4-dimethyl- 0.0193573267900279 0.53979773
Total:84  Current:38    [First] [Prev] [Next] [Last]